Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06273436

Healing, Equity, Advocacy and Respect for Mamas

Comparing Standard of Care Versus a Technology-Based Approach To Reduce Postpartum Emergency Department Visits

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
2,894 (estimated)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
Female
Age
16 Years – 49 Years
Healthy volunteers
Not accepted

Summary

The goal of the proposed research is to test the comparative effectiveness of AIM safety bundles for post-partum women delivered in-person vs. via text/phone to improve early detection of and timely care for complications during the first six weeks postpartum for women experiencing significant health disparities.

Detailed description

The purpose of the study is to learn if a program for newborn mom's can improve detection of complications after delivery and help women get medical care quickly and easily. Participants will be asked to complete a survey at the time of enrollment and at 3 additional times. All surveys can be completed via cell-phone or email. All women will be followed for 1-year after delivery. Women that enroll will be assigned to one of two groups: usual in person care OR usual in-person care PLUS a text message-based program that will ask about sign and symptoms of complications that may occur after delivery. If there is a concern, a nurse advocate will call on the phone to discuss options and help refer to care if needed. Participants will be paid for their time in completing surveys.

Conditions

Interventions

TypeNameDescription
OTHERH.E.A.R. for MamasH.E.A.R. for Mamas is a patient and provider informed, multicomponent intervention that uses simple text/phone-based screenings to systematically and frequently monitor women for postpartum complications, chronic conditions and SDoH (Social Determinants of Health) and provides patients with immediate feedback and recommendations based on their screenings.

Timeline

Start date
2024-05-28
Primary completion
2028-11-30
Completion
2030-03-30
First posted
2024-02-22
Last updated
2026-02-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06273436. Inclusion in this directory is not an endorsement.